BHF Kleinwort Benson Group’s Regulus Therapeutics RGLS Stock Holding History

BHF Kleinwort Benson Group’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$89K	Buy	+107	New	+$85.1K	﹤0.01%	361

Other funds holding RGLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BHF Kleinwort Benson Group's RGLS Position: Q1 2016 in Review

BHF Kleinwort Benson Group opened a new position in Regulus Therapeutics (RGLS) in Q1 2016: 107 shares worth $89K. The stake represents ﹤0.01% of the portfolio and ranks #361 among its holdings.

101 funds tracked by Wall St. Rank hold RGLS as of Q1 2016.

BHF Kleinwort Benson Group held 107 shares of Regulus Therapeutics worth $89K as of Q1 2016.
Regulus Therapeutics was a new BHF Kleinwort Benson Group position in Q1 2016.
Regulus Therapeutics made up ﹤0.01% of BHF Kleinwort Benson Group's portfolio in Q1 2016, its #361 holding.
101 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.